BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 4
• 5
• 6
• 7
• 8
• 9
• 10
• 11
• 12
• 13
• 14
• 15
• 16
• 17
• 18
• 19
• 20
• 21
• 22
• 23
• 24
• 25
• 26
• 27
• 28
• 29
• 30
• 31

• Deals

  InflaRx Reports First Quarter 2019 Financial & Operating Results

  InflaRx reported financial and operating results for the first quarter ended March 31, 2019.

  May 23, 2019

   · 

  5 min read
• 

  Deals

  Auris Medical Holding Ltd Provides Corporate Update

  Auris Medical Holding Ltd. provided a business update, including a review of recent clinical, regulatory and operational highlights and progress.

  May 23, 2019

   · 

  9 min read
• Deals

  Polarean Imaging Plc London Investor Symposium Wednesday 12 June 2019

  Polarean Imaging plc, the medical-imaging technology company, with a proprietary drug-device combination product for the magnetic resonance imaging market, announces it will be hosting a Capital Markets Day for all investors on Wednesday 12 June 2019.

  May 23, 2019

   · 

  1 min read
• 

  Technology mix the key to unlocking enzyme dynamics

  Australian researchers have used a unique combination of cutting-edge technologies to discover a biochemical mechanism fundamental to life.

  May 23, 2019

   · 

  2 min read
• Results Announced from Two Renal Denervation Studies at EuroPCR Show Positive Outcomes in High-Risk Hypertensive Patients

  Late-Breaking Clinical Trial Results and Updated Global SYMPLICITY Registry Data Demonstrate Long-Term Results of RDN for Uncontrolled Hypertension

  May 23, 2019

   · 

  4 min read
• GamaMabs Pharma to present updated results at 2019 ASCO Annual Meeting from the First-In-Human clinical study of murlentamab in advanced gynecological cancers

  Objective responses, good safety and evidence of stimulation of the immune system observed under murlentamab (GM102) single agent and in combination with chemotherapy

  May 23, 2019

   · 

  4 min read
• The top 25 medical lab tests around the world

  A new study has revealed the 25 most common diagnostic lab tests in the world, information that could be key for any jurisdiction looking to develop universal health coverage.

  May 23, 2019

   · 

  2 min read
• Motif Bio to Evaluate Orphan Disease Opportunity for Iclaprim in Ophthalmology

  Motif Bio plc announced that the Company has signed an agreement with Otto-von-Guericke University Magdeburg to conduct a study evaluating iclaprim in an in vitro model of ocular toxoplasmosis.

  May 23, 2019

   · 

  4 min read
• Deals

  Motif Bio plc AGM Statement

  Motif Bio plc, a clinical-stage biopharmaceutical company specialising in developing novel antibiotics, announces that at the Company’s AGM held earlier the Company provided the following review of key aspects of its business and growth strategy.

  May 23, 2019

   · 

  3 min read
• 

  Eli Lilly’s Generic Insulin Hits Market at Half the Price of Branded Counterpart

  Lispro Injection is a generic of Eli Lilly’s Humalog that is now available to diabetes patients at a 50% lower list price.

  May 23, 2019

   · 

  3 min read

   · 

  Alex Keown